Interleukin 6/gp130 axis promotes neural invasion in pancreatic cancer

Interleukin 6/gp130 axis promotes neural invasion in pancreatic cancer

Abstract Background Nerve invasion (N‐inv) is an important prognostic factor in pancreatic ductal adenocarcinoma (PDAC). Elucidation of circulating N‐inv stimulators could provide deeper insights and novel perspectives for PDAC therapy. The interleukin (IL)‐6/gp130 axis was evaluated in this study a...

Full description

Bibliographic Details
Main Authors:	Hidetaka Suzuki, Shuichi Mitsunaga, Masafumi Ikeda, Takao Aoyama, Kazumi Yoshizawa, Masayuki Yamaguchi, Masami Suzuki, Minoru Narita, Toshikatsu Kawasaki, Atsushi Ochiai
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Series:	Cancer Medicine
Subjects:	mouse models pancreatic cancer pancreatic ductal adenocarcinoma translational research
Online Access:	https://doi.org/10.1002/cam4.4823

Similar Items

Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer
by: Hidetaka Suzuki, et al.
Published: (2021-09-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Pathomorphological characteristics of the restructuring of pancreatic ductal system in chronic pancreatitis
by: Kovalenko I.S.
Published: (2013-01-01)

Recent Developments in the Treatment of Pancreatic Cancer
by: Jorge Paulino, et al.
Published: (2023-10-01)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
by: Jessica Allen, et al.
Published: (2020-10-01)

Pancreatic tail cancer in the setting of pancreatitis with a review of the literature: A case report
by: Shinji Rho, et al.
Published: (2023-10-01)

Differentiating benign from malignant pancreatic cysts on computed tomography
by: Rajesh Kumar Yadav, et al.
Published: (2020-01-01)

Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
by: Jun Ushio, et al.
Published: (2021-03-01)

Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study
by: Naohiro Kato, et al.
Published: (2023-05-01)

Utility of Contrast-Enhanced Computed Tomography for Differentiating Pancreatic Ductal Adenocarcinoma from Inflammatory Mass in Chronic Calcific Pancreatitis
by: Thara Pratap, et al.
Published: (2024-01-01)

Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
by: Tatiana J. Carneiro, et al.
Published: (2022-08-01)

Management of Metastatic Pancreatic Cancer—Comparison of Global Guidelines over the Last 5 Years
by: Monika Pajewska, et al.
Published: (2023-09-01)

Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology
by: Alin Mihai Vasilescu, et al.
Published: (2021-11-01)

Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
by: Tomonari Shimagaki, et al.
Published: (2023-11-01)

Correlations of miR-1290 and miR-191-5p with laboratory parameters as a useful test to differentiate pancreatic cancer from chronic pancreatitis: preliminary study
by: Małgorzata Guz, et al.
Published: (2023-06-01)

SWIP—a stabilized window for intravital imaging of the murine pancreas
by: Wei Du, et al.
Published: (2022-06-01)

Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells reported in an asymptomatic patient: a rare case and literature review
by: Ramen Sakhi, et al.
Published: (2017-12-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer
by: Nina A. Hering, et al.
Published: (2023-01-01)

The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
by: Rachel R. Tindall, et al.
Published: (2024-03-01)

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
by: Marwa Elsayed, et al.
Published: (2021-04-01)

Alpha Smooth Muscle Actin (αSMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis
by: Katarzyna Winter, et al.
Published: (2021-12-01)

Pancreatic Neoplasms: CT Evaluation of the Uncommon Presentations of Common Lesions and Common Presentations of the Uncommon Lesions!
by: Sneha Satish Deshpande, et al.
Published: (2022-12-01)

An Autopsy Case of Anaplastic Pancreatic Ductal Carcinoma (Spindle Cell Type) Multiple Onset in the Pancreas
by: Hiroyuki Ito, et al.
Published: (2019-04-01)

Radiomics and Its Applications and Progress in Pancreatitis: A Current State of the Art Review
by: Gaowu Yan, et al.
Published: (2022-06-01)

Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis
by: Yuko Mataki, et al.
Published: (2021-03-01)

Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study
by: Shin Miura, et al.
Published: (2021-09-01)

The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer
by: Sherise Rogers, et al.
Published: (2023-12-01)

The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analysis Using 2001–2018 United States Cancer Statistics Databases
by: Yi Jiang, et al.
Published: (2024-02-01)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
by: Bathiya Ratnayake, et al.
Published: (2020-07-01)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
by: Natalia Michalak, et al.
Published: (2023-06-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01)

Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis
by: Takuya Takayanagi, et al.
Published: (2023-03-01)

Retroperitoneal lymphangioma as the final diagnosis of a middle-aged woman with abdominal pain: a case report
by: Hamid Asadzadeh Aghdaei, et al.
Published: (2023-03-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2020-08-01)

Diagnostic Ability and Safety of Repeated Pancreatic Juice Cytology Using an Endoscopic Nasopancreatic Drainage Catheter for Pancreatic Ductal Adenocarcinoma: A Multicenter Prospective Study
by: Shinya Nakamura, et al.
Published: (2023-08-01)

Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case–control study
by: Akinobu Koiwai, et al.
Published: (2023-06-01)